ZALEVSKY JONATHAN (Chief R&D Officer) sold 26.4% of their position (5.54K shares) of NEKTAR THERAPEUTICS on the open market
Open‑market sale worth $336.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/17/2026ACC: 0001193125-26-274534
Officer· Chief R&D Officer
Since Oct 2019
-5.54K
Net shares
Net seller
$336.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.54K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.54K
Price / share
$60.71
Trade value
$336.21K
% of position
26.4%
6/15/2026
20.98K→15.44K
Total
Net shares
−5.54K
Net value
-$336.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2026 | S · Sale | −5.54K | $60.71 | $336.21K | 26.4% | 20.98K | 15.44K |
| Total | −5.54K | -$336.21K | ||||||
Derivative Transactions0
No derivative transactions reported